Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
| Sales | 3,296 | 4,741 | 5,141 | 3,014 | 3,398 |
| Cost of Goods | 1,904 | 3,348 | 3,023 | 1,034 | 2,573 |
| Gross Profit | 1,153 | 1,393 | 2,118 | 2,642 | 825 |
| Operating Expenses | 4,251 | 3,698 | 3,078 | 3,811 | 4,157 |
| Operating Income | -1,955 | -1,957 | -937 | -1,797 | -2,759 |
| Interest Expense | 71 | 67 | 66 | 68 | 69 |
| Other Income | 38 | 88 | 98 | -594 | 115 |
| Pre-tax Income | -1,988 | -1,936 | -905 | -2,460 | -2,713 |
| Income Tax | 11 | 6 | 4 | 8 | -3 |
| Net Income Continuous | -1,999 | -1,942 | -910 | -2,468 | -2,709 |
| Net Income | $-1,999 | $-1,942 | $-910 | $-2,468 | $-2,709 |
| EPS Basic Total Ops | -9.60 | -9.60 | -4.80 | -12.80 | -13.60 |
| EPS Basic Continuous Ops | -9.69 | -9.46 | -4.50 | -12.48 | -13.98 |
| EPS Diluted Total Ops | -9.60 | -9.60 | -4.80 | -12.80 | -13.60 |
| EPS Diluted Continuous Ops | -9.69 | -9.46 | -4.50 | -12.48 | -13.98 |
| EBITDA(a) | $-1,955 | $-1,957 | $-937 | $-1,797 | $-2,759 |